Ricardo Maré

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 184 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +3

Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks

Priya S. Kishnani, Jordi Díaz‐Manera, António Toscano et al. · JAMA Neurology · 2023 · 55 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +8

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke

Grant Mair, Rüdiger von Kummer, Zoë Morris et al. · Neurology · 2015 · 41 citations · Full text

Medicine, Neurology, Radiology +17

Screening for Pompe disease in a Portuguese high risk population

Vânia Almeida, Isabel Conceição, Isabel Fineza et al. · Neuromuscular Disorders · 2017 · 19 citations · Full text

Medicine, Health Sciences, Preventive Medicine +6

Reversible cerebellar syndrome induced by hypomagnesemia

Ana Filipa Santos, Filipa Sousa, Margarida Rodrigues et al. · Neurology and Clinical Neuroscience · 2015 · 17 citations · Full text

Medicine, Neurology, Neuroscience +17